| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new name a new mission: APhA goes forward seeking recognition for pharmacists’skills abilities
|
|
|
2003
|
|
5S1 |
p. S3-S5
3 p.
|
artikel
|
| 2 |
2003 APhA Awards and Honors
|
|
|
2003
|
|
5S1 |
p. S60-S63
4 p.
|
artikel
|
| 3 |
2002 APhA Treasurer’s Report
|
Anderson, Lowell J.
|
|
2003
|
|
5S1 |
p. S63-S64
2 p.
|
artikel
|
| 4 |
Between the ‘No Longer’ and the ‘Not Yet’
|
Andersen, Mary Louise Tigue
|
|
2003
|
|
5S1 |
p. S6-S9
4 p.
|
artikel
|
| 5 |
Building Working Relationships With Providers
|
|
|
2003
|
|
5S1 |
p. S44-S45
2 p.
|
artikel
|
| 6 |
Coaching Skills for Pharmacists
|
|
|
2003
|
|
5S1 |
p. S38-S39
2 p.
|
artikel
|
| 7 |
Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors
|
Neumiller, Joshua J.
|
|
2009
|
|
5S1 |
p. S16-S29
|
artikel
|
| 8 |
Efficacy and safety of incretin-based therapies: Clinical trial data
|
White, John
|
|
2009
|
|
5S1 |
p. S30-S40
|
artikel
|
| 9 |
Emerging Technology at the Point of Care
|
|
|
2003
|
|
5S1 |
p. S50-S51
2 p.
|
artikel
|
| 10 |
Fate of the beta-cell in the pathophysiology of type 2 diabetes
|
Keith Campbell, R.
|
|
2009
|
|
5S1 |
p. S10-S15
|
artikel
|
| 11 |
Federal Pharmacists: Leading Through APhA
|
|
|
2003
|
|
5S1 |
p. S15-
1 p.
|
artikel
|
| 12 |
Managing Dyslipidemia: Putting the New Guidelines to Work
|
|
|
2003
|
|
5S1 |
p. S24-S25
2 p.
|
artikel
|
| 13 |
MenoPAUSE: Taking a Second Look at the Role of HRT
|
|
|
2003
|
|
5S1 |
p. S34-S35
2 p.
|
artikel
|
| 14 |
New Options in Herpes Management
|
|
|
2003
|
|
5S1 |
p. S22-S23
2 p.
|
artikel
|
| 15 |
Optimizing Outcomes in Rheumatoid Arthritis
|
|
|
2003
|
|
5S1 |
p. S16-S17
2 p.
|
artikel
|
| 16 |
OTC Medicines Update
|
|
|
2003
|
|
5S1 |
p. S28-S29
2 p.
|
artikel
|
| 17 |
Persistent Pain Management for Improved Quality of Life
|
|
|
2003
|
|
5S1 |
p. S30-S31
2 p.
|
artikel
|
| 18 |
PET Practice in Nuclear Pharmacy
|
|
|
2003
|
|
5S1 |
p. S42-S43
2 p.
|
artikel
|
| 19 |
Pharmacist roles in the management of patients with type 2 diabetes
|
Sisson, Evan
|
|
2009
|
|
5S1 |
p. S41-S45
|
artikel
|
| 20 |
Practical Tools for Medication Safety in Acute Care
|
|
|
2003
|
|
5S1 |
p. S48-S49
2 p.
|
artikel
|
| 21 |
Reaching Beyond the Pharmacy Bench: Impressions of Academic Community Pharmacy Practice
|
Cerulli, Jennifer
|
|
2003
|
|
5S1 |
p. S10-S14
5 p.
|
artikel
|
| 22 |
Report of the 2003 APhA House of Delegates
|
|
|
2003
|
|
5S1 |
p. S56-S59
4 p.
|
artikel
|
| 23 |
Risk Management From a Collaborative Perspective
|
|
|
2003
|
|
5S1 |
p. S54-S55
2 p.
|
artikel
|
| 24 |
Smoking Cessation: Pharmacists Helping Patients Kick the Habit
|
|
|
2003
|
|
5S1 |
p. S26-S27
2 p.
|
artikel
|
| 25 |
Studying Pharmaceutical Care: Difficult But Necessary
|
|
|
2003
|
|
5S1 |
p. S36-S37
2 p.
|
artikel
|
| 26 |
The Pharmacist as a Primary Care Provider for the Medically Underserved
|
|
|
2003
|
|
5S1 |
p. S52-S53
2 p.
|
artikel
|
| 27 |
The Pharmacist’s Role in Managing Patients with Alzheimer’s Disease
|
|
|
2003
|
|
5S1 |
p. S20-S21
2 p.
|
artikel
|
| 28 |
The Use of Power and Influence: Managing Without Authority
|
|
|
2003
|
|
5S1 |
p. S40-S41
2 p.
|
artikel
|
| 29 |
Treatment of Acute and Chronic Heart Failure
|
|
|
2003
|
|
5S1 |
p. S18-S19
2 p.
|
artikel
|
| 30 |
Type 2 diabetes: Epidemiology and treatment, pathophysiology, new therapeutics, and the evolving role of the pharmacist
|
Keith Campbell, R.
|
|
2009
|
|
5S1 |
p. S2
|
artikel
|
| 31 |
Type 2 diabetes: Where we are today: An overview of disease burden, current treatments, and treatment strategies
|
Keith Campbell, R.
|
|
2009
|
|
5S1 |
p. S3-S9
|
artikel
|
| 32 |
Unraveling the Mysteries of Syndrome X
|
|
|
2003
|
|
5S1 |
p. S32-S33
2 p.
|
artikel
|
| 33 |
Why Wrestle When You Can Dance? Optimizing Outcomes with Motivational Interviewing
|
|
|
2003
|
|
5S1 |
p. S46-S47
2 p.
|
artikel
|
Tijdschrift beschrijving